Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001731122-20-001338
Filing Date
2020-12-28
Accepted
2020-12-28 17:27:32
Documents
48
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K e2298_10k.htm   iXBRL 10-K 1050290
2 EXHIBIT 21.1 e2298_ex21-1.htm EX-21.1 3514
3 EXHIBIT 23.1 e2298_ex23-1.htm EX-23.1 4686
4 EXHIBIT 31.1 e2298_ex31-1.htm EX-31.1 13534
5 EXHIBIT 31.2 e2298_ex31-2.htm EX-31.2 13518
6 EXHIBIT 32.1 e2298_ex32-1.htm EX-32.1 6266
7 GRAPHIC image_001.jpg GRAPHIC 48203
8 GRAPHIC img_002.jpg GRAPHIC 49733
  Complete submission text file 0001731122-20-001338.txt   3777492

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE avxl-20200930.xsd EX-101.SCH 27705
10 XBRL CALCULATION FILE avxl-20200930_cal.xml EX-101.CAL 27149
11 XBRL DEFINITION FILE avxl-20200930_def.xml EX-101.DEF 83007
12 XBRL LABEL FILE avxl-20200930_lab.xml EX-101.LAB 231368
13 XBRL PRESENTATION FILE avxl-20200930_pre.xml EX-101.PRE 168637
14 EXTRACTED XBRL INSTANCE DOCUMENT e2298_10k_htm.xml XML 396448
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37606 | Film No.: 201419254
SIC: 8731 Services-Commercial Physical & Biological Research